| What's new in psoriasis? Analysis of the clinical significance of new guidelines and systematic reviews on psoriasis published in 2008 and 2009. | |
| | |
MedLine Citation:
|
PMID: 20545953 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This review summarizes the clinical importance of 18 systematic reviews and guidelines on psoriasis published or indexed between November 2008 and October 2009. The topics covered include guidance on the use of topical, systemic and biological therapies for the treatment of psoriasis; comorbidities associated with psoriasis; and complementary therapies for psoriasis. A similar and more detailed review to this appeared in the 2009 Annual Evidence Update on Psoriasis from NHS Evidence - Skin Disorders in November 2009. |
| | |
Authors:
|
R B Warren; B C Brown; D J C Grindlay; C E M Griffiths |
Related Documents
:
|
2477993 - Macroamylasemia: a simple stepwise approach to diagnosis. 12593543 - Type iii tympanoplasties: the sherbrooke experience. 15210083 - The unrecognised french bse epidemic. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Clinical and experimental dermatology Volume: 35 ISSN: 1365-2230 ISO Abbreviation: Clin. Exp. Dermatol. Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-13 Completed Date: 2010-10-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7606847 Medline TA: Clin Exp Dermatol Country: England |
Other Details:
|
Languages: eng Pagination: 688-91; quiz 692 Citation Subset: IM |
Copyright Information:
|
© 2010 The Author(s). Journal compilation © 2010 British Association of Dermatologists. |
Affiliation:
|
Dermatological Sciences, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. richard.warren@manchester.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Dermatologic Agents
/
therapeutic use Humans Immunologic Factors / therapeutic use Practice Guidelines as Topic* Psoriasis / drug therapy* Review Literature as Topic* |
| Chemical | |
Reg. No./Substance:
|
0/Dermatologic Agents; 0/Immunologic Factors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: T-cell clone associated with efalizumab therapy.
Next Document: Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case-control study...